Background: Blood transfusions are banned by the World Anti-Doping Agency as a form of "blood doping". A method of detection of homologous blood transfusion (HBT) has been implemented by the accredited anti-doping laboratories worldwide; however, no internationally recognized method has been finalized so far for the direct detection of autologous blood transfusions, which can at present be revealed only by targeted longitudinal profiling of key blood parameters.
Detecting autologous blood transfusion in doping control: biomarkers of blood aging and storage measured by flow cytofluorimetry / Donati, F; Acciarini, Roberta; De Benedittis, Ilenia; de la Torre, Xavier; Pirri, Daniela; Prete, Mariangela; Stampella, Alessandra; Vernucci, Enza; Botre, Francesco. - In: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. - ISSN 1873-4316. - STAMPA. - (2018). [10.2174/1389201019666180405165118]
Detecting autologous blood transfusion in doping control: biomarkers of blood aging and storage measured by flow cytofluorimetry
Botre, Francesco
2018
Abstract
Background: Blood transfusions are banned by the World Anti-Doping Agency as a form of "blood doping". A method of detection of homologous blood transfusion (HBT) has been implemented by the accredited anti-doping laboratories worldwide; however, no internationally recognized method has been finalized so far for the direct detection of autologous blood transfusions, which can at present be revealed only by targeted longitudinal profiling of key blood parameters.| File | Dimensione | Formato | |
|---|---|---|---|
|
Donati_Detecting-Autologous_2018.pdf
solo gestori archivio
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
2.25 MB
Formato
Adobe PDF
|
2.25 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
